In its preliminary results for the year ending 31st December 2022, Tower Resources PLC (AIM: TRP), an Africa-based oil and gas firm, underscored its financing ventures and developments in exploration
In its preliminary results for the year ending 31st December 2022, Tower Resources PLC (AIM: TRP), an Africa-based oil and gas firm, underscored its financing ventures and developments in exploration
Superdrug to sell Salistick™, the first ever saliva pregnancy test, initially in 400 stores and online Salistick™ also to launch on the Abingdon Simply Test website
The executives of Royal Mail have reportedly considered the possibility of placing their struggling postal business into administration due to an ongoing dispute with the Communication Workers Union (CWU).
Abingdon Health’s CDMO service to support Senzo in leveraging its innovative, high-accuracy Amplified Lateral Flow (ALF) point-of-care diagnostics platform technology across multiple product opportunities
York, U.K. 7 March 2023: Abingdon Health plc (AIM: ABDX), a leading international lateral flow contract development and manufacturing organisation (CDMO), announces the granting of an additional patent for its
York, U.K. 28 February 2023: Abingdon Health plc (AIM: ABDX), a leading international lateral flow contract development and manufacturing organisation (CDMO), provides its half-year trading update for the six months
IOG plc (“IOG”, or “the Company”), (AIM: IOG.L), the Net Zero UK gas and infrastructure operator focused on high-return projects, provides an update on the Southwark field development:
Stock markets in the UK are either heading into a recession or already are. Many investors are concerned about what the future holds for them.
As Europe’s postal services develop, Britain and Germany are now outliers as Europe’s postal services evolve
York, U.K. 19 December 2022: Abingdon Health plc (AIM: ABDX), a leading international developer and manufacturer of high quality, rapid diagnostic tests, announces the establishment of a new Long Term Incentive Plan
York, U.K. 24 November 2022: Abingdon Health plc (AIM: ABDX), a leading international developer and manufacturer of high quality, rapid diagnostic tests, announces its preliminary results for the year ended
Royal Mail suffered a loss of over £200m in its first half. This was due to ongoing strikes, a drop in parcel deliveries, and the inability to restructure while at